Amid swirling speculation, Bausch + Lomb ($BLCO), a global leader in the contact lens supply industry, is reportedly ...

Comfort was the name of the game when OT spoke with contact lens manufacturers and suppliers about recent trends and launches ...

Eye health firm Bausch + Lomb has received marketing approval for its full range of enVista Envy vision intraocular lenses (IOL) from the US Food and Drug Administration (FDA). Following the ...

Bausch + Lomb is also in the process of seeking regulatory approvals for the lens in additional markets. The enVista Envy hydrophobic acrylic IOL is indicated for primary implantation in the ...

Bausch + Lomb is one of the leading contact-lens suppliers in the world. Bausch Health and Goldman Sachs declined to comment to the FT. Bausch + Lomb is headed by Brent Saunders, a longtime ...

Monday was an eventful day for Bausch ... lenses (IOLs). These are implanted in the eye to treat cataracts and other vision disorders. Combined, these latest developments with Bausch + Lomb ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Bausch + Lomb Corporation (BLCO – Research Report) yesterday and set a ...

lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant ...